C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: Correlations with birth weight

https://doi.org/10.1016/0002-9378(93)90137-8Get rights and content

Objective: Our purpose was to determine the correlation between birth weight and hormones or growth factors believed to be involved in fetal growth: insulin, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1.

Study Design: Five hundred thirty-eight cord serum samples were analyzed for insulin-like growth factor-l, insulin-like growth factor-ll, C-peptide, and insulin-like growth factor binding protein-1 by immunoassay. Samples included all gestational ages in the third trimester and a large range of birth weights.

Results: Cord serum insulin-like growth factor-l concentrations increased until 39 weeks (+84% from 28 to 29 weeks), followed by a 21% decline at 41 weeks. Insulin-like growth factor-I levels were decreased by 40% in small-for-gestational-age (< 10th percentile) newborns and were increased by 28% in large-for-gestational-age (>90th percentile) newborns in the absence of diabetes. Insulin-like growth factor-I levels were best correlated with birth weight (R = 0.48, p < 0.001). Cord serum insulin-like growth factor-II concentrations were sixfold to tenfold higher than those of insulin-like growth factor-I and were 8% to 10% (p < 0.001) higher in large-for-gestational-age than in average-weight and small-for-gestational-age newborns. Cord serum C-peptide concentrations were 28% and 34% higher in large-for-gestational-age than in average-for-gestational-age and small-for-gestational-age newborns, respectively. Insulin-like growth factor binding protein-1 levels were increased in preterm average-for-gestational-age and in term small-for-gestational-age newborns compared with term average-for-gestational-age newborns and showed a negative correlation with birth weight (R = − 0.43, n = 131, p < 0.001). Insulin-like growth factor binding protein-1 was not correlated with C-peptide concentrations.

Conclusions: Insulin-like growth factors I and II and insulin are all related to fetal growth and weight gain, and insulin-like growth factor-l correlates best with birth weight. Insulin is mainly related to fetal overgrowth (macrosomia). Insulin-like growth factor binding protein-1 may be a growth inhibitor in the fetus.

References (25)

  • NA Samaan et al.

    Insulin-like growth factor II and non-suppressible insulin-like activity levels in newborns

    Am J Obstet Gynecol

    (1990)
  • DL Economides et al.

    Plasma insulin in appropriate- and small-for-gestational-age fetuses

    Am J Obstet Gynecol

    (1989)
  • DJ Hill et al.

    Insulin as a growth factor

    Pediatr Res

    (1985)
  • AJ D'Ercole

    The insulin-like growth factors and fetal growth

  • VKM Han et al.

    Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characteriza- tion, and distribution

    J Clin Endocrinol Metab

    (1988)
  • C Lassarre et al.

    Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation

    Pediatr Res

    (1991)
  • RA Crystal et al.

    Insulin-like growth factor binding protein profiles in human fetal cord sera: ontogeny during gestation and differences in newborns with IUGR and LGA newborns

  • AM Taylor et al.

    The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics

    Clin Endocrinol (Oxf)

    (1990)
  • AM Suikkari et al.

    Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin

    J Clin Endocrinol Metab

    (1989)
  • LO Lubchenco et al.

    Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation

    Pediatrics

    (1963)
  • J Verhaeghe et al.

    The effects of systemic insulin, insulinlike growth factor I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats

    J Endocrinol

    (1992)
  • RR Bowsher et al.

    Measurement of insulin-like growth factor -II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids

    Endocrinology

    (1991)
  • Cited by (225)

    • Pregnancy and the fetus

      2020, Handbook of Diagnostic Endocrinology
    View all citing articles on Scopus
    a

    From the Department of Obstetrics and Gynecology, Katholieke Universiteit Leuven.

    b

    Laboratorium voor Experimented Geneeskunde en Endocrinologie, Katholieke Universiteit Leuven.

    View full text